K. Mezei

A comparison of eflapegrastim to pegfilgrastim in the management of chemotherapy‐induced neutropenia in patients with early‐stage breast cancer undergoing cytotoxic chemotherapy (RECOVER): A Phase 3 study

I. Láng, L. Schwartzberg, S. Chawla, 2020, Cancer medicine.

Pemetrexed in combination with cisplatin versus cisplatin monotherapy in patients with recurrent or metastatic head and neck cancer

D. Shin, C. Reuter, R. Hitt, 2012, Cancer.

An open‐label, dose‐ranging study of Rolontis, a novel long‐acting myeloid growth factor, in breast cancer

I. Láng, Z. Horváth, A. Chan, 2018, Cancer medicine.